RIEMSER Pharma GmbH Revenue and Competitors

Greifswald, USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • RIEMSER Pharma GmbH's estimated annual revenue is currently $22.1M per year.(i)
  • RIEMSER Pharma GmbH's estimated revenue per employee is $201,000

Employee Data

  • RIEMSER Pharma GmbH has 110 Employees.(i)
  • RIEMSER Pharma GmbH grew their employee count by -34% last year.

RIEMSER Pharma GmbH's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is RIEMSER Pharma GmbH?

RIEMSER sells, licenses, markets and distributes pharmaceutical products. Over 400 approvals worldwide, of which 28 were granted in the last three years, stand testament to the special expertise of RIEMSER for the approval and opening of new markets for pharmaceutical products. The product range specifically covers prescription drugs used to treat serious diseases in the therapeutic areas of oncology, infectiology, neurology, cardiovascular, dermatology, and rheumatology, as well as the treatment of tuberculosis, obesity and primary axillary hyperhidrosis. Medicinal products and food supplements complement the portfolio. Besides its international group headquarters in Berlin, the company has three other locations in Germany. In 2014 and 2015, RIEMSER acquired the subsidiaries Keocyt based in France and Intrapharm based in England. Since October 2019, RIEMSER is also present in Spain through its subsidiary RIEMSER Iberia. In addition, it has established an international distribution network. RIEMSER is a portfolio company of Ardian, one of the world?s leading private investment companies.

keywords:N/A

N/A

Total Funding

110

Number of Employees

$22.1M

Revenue (est)

-34%

Employee Growth %

N/A

Valuation

N/A

Accelerator

RIEMSER Pharma GmbH News

2022-04-13 - Global Tuberculosis Drug Market Business is Booming | Major Players-Brown & Burk, Cipla, Mylan N.V., Sanofi,

Ltd., RIEMSER Pharma GmbH, Sanofi, Sequella Inc., and Strides Pharma Science Limited amongst others. Get PDF sample report with all related...

2012-09-03 - Riemser Arzneimittel Acquired by AXA Private Equity

Riemser Arzneimittel AG, a Greifswald, Germany-based international specialty pharmaceutical company, has been acquired by private equity firm AXA Private Equity. AXA has acquired the shareholdings of Riemser’s founding Braun family and those of various minority stakeholders, including TVM Capit ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A31613%N/A